Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,276 | -34,044 | -26,148 | -14,864 | -38,422 |
| Depreciation Amortization | 1,727 | 1,632 | 1,126 | 665 | 1,370 |
| Accounts payable and accrued liabilities | -9,473 | -9,762 | -8,255 | -3,084 | 4,263 |
| Other Working Capital | -10,074 | -11,425 | -11,166 | -3,372 | 5,891 |
| Other Operating Activity | 11,325 | 11,527 | 9,944 | 4,153 | -163 |
| Operating Cash Flow | $-45,771 | $-42,072 | $-34,499 | $-16,502 | $-27,061 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 229 | 166 | 28 | -7 | -440 |
| Purchase Of Investment | -3,671 | -3,671 | -3,672 | -1,027 | -174,853 |
| Sale Of Investment | 77,502 | 66,094 | 49,021 | 20,540 | 116,587 |
| Investing Cash Flow | $74,060 | $62,589 | $45,377 | $19,506 | $-58,706 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 93,514 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -1,907 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $0 | $91,607 |
| Exchange Rate Effect | 46 | 58 | 58 | -21 | 49 |
| Beginning Cash Position | 8,305 | 8,305 | 8,305 | 8,305 | 2,416 |
| End Cash Position | 36,640 | 28,880 | 19,241 | 11,288 | 8,305 |
| Net Cash Flow | $28,335 | $20,575 | $10,936 | $2,983 | $5,889 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,771 | -42,072 | -34,499 | -16,502 | -27,061 |
| Capital Expenditure | -7 | -7 | -7 | -7 | -440 |
| Free Cash Flow | -45,778 | -42,079 | -34,506 | -16,509 | -27,501 |